“DESIGN AND CHARCTERIZATION OF MICROSPONGES OF POSACONAZOLE FOR TOPICAL DELIVERY”
DOI:
https://doi.org/10.61841/s23vyc68Keywords:
Polymeric Microsponges (PMS),, Microsponges delivery systems (MDS), PosaconazoleAbstract
Carrier technology offers an intelligent approach for drug delivery by coupling the drug to a carrier particle such as microspheres, nanoparticles, etc. to control the delivery rate of active agents to a predetermined site in human body. The study aimed towards formulation development and evaluation of polymeric micro sponges consisting of noncollapsible structures with porous surface through which active ingredients are released in a controlled manner
Preparation of Posaconazole microsponges is done by quasi emulsion solvent diffusion method followed by preparation of microsponge Posaconazole gel. Charactization of Posaconazole microsponges is done by various physical parameters e.g. Particle size (Microscopy), Morphology and Surface topography, Characterization of pore structure, Loading efficiency and production yield, Drug content, Compatibility studies, Resiliency as well as by In vitro drug release studies e.g. drug release study, release kinetics, In vitro anti-microbial study etc. This system has been utilized for the improvement of performance of topically applied drug. MDS technology is now being presently used in cosmetics, over-the-counter(OTC) skin care, sunscreens and prescription products.
Downloads
References
1. Chowdary K.P.R., Rao Y.S. Mucoadhesive Microspheres for Controlled Drug Delivery. Biol.Pharm. Bull. 2004; 27(11): 1717-24.
2. Nacht S., Kantz M. The Microsponge: A Novel Topical Programmable Delivery System. In Topical Drug Delivery Systems. Marcel Dekker, New York, 1990; 299–325.
3. Embil K., Nacht S. The microsponge delivery system (MDS) a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul, 1996; 13: 575–88.
4. Chadawar V, Shaji J: Microsponge delivery system. Current Drug Delivery 2007; 4: 123- 129.
5. D’souza JI, Masvekar RR, Pattekari PP, Pudi SR, More HN: Microspongic delivery of fluconazole for topical application. Indo-Japanese Int. Conference on Adv. Pharm. Res. And Tech 2004; 76.
6. Aritomi H, Yamasaki Y, Yamada K, Honda H, Koshi M, Development of sustained release formulation of chlorpheniramine maleate using powder coated microsponges prepared by dry impact blending method, J Pharm Sci Tech, 1996; 56: 49- 56.
7. Kawashima Y., Niwa T., Takeuchi H., Hino T., Itoh Y., Furuyama S. Controlof Prolonged Drug Release and Compression Properties of Ibuprofen Microsponges
with Acrylic Polymer, Eudragit RS by changing their Intraparticle Density. Chem. Pharm. Bull. 1992; 40(1): 196-201.
8. Emanuele A.D. and Dinarvand R. Preparation, characterization and drug release from thermo responsive microspheres. Int. J. Pharmaceutics, 1995; 118: 237-242.
9. Vyas SP, Khar RK: Targeted and controlled drug delivery- Novel carrier system. CBS Publication, New Delhi, Edition 1, 2002; 453.
10. Embil K. and Nacht S: The microsponge delivery system (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J.Microencapsulation 1996; 308: 124-132.
11. D’souza J.I., Masvekar R.R., Pattekari P.P., Pudi S.R., More H.N. Microspongic Delivery Of Fluconazole For Topical Application.indo-Japanese International Conference On Advances In Pharmaceutical Research And Technology, 2004; 76.
12. Elvehgari M, Siahi-Shadbad MR, Azarmi S, Gary P, Martin, Nokhodchi A: The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies.International Journal of Pharmaceutics 2006; 308: 124-132.
13. Amrutiya N, Bajaj A & Madan M: Development of microsponges for topical delivery of mupirocin. AAPS PharmSciTech 2009; 10(2): 402-409.
14. D’souza JI, Harinath NM: Topical anti-inflammatory gels of fluocinolone acetonide entrapped in eudragit based microsponge delivery system. Research J Pharm and Tech 2008; 1: 502-506.
15. Grimes PE: A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and post inflammatory hyper-pigmentation. Cutis, Vitiligo and Pigmentation Institute of Southern California, Los Angeles, 2004; 74(6): 362-368.
16. Vyas SP, Khar RK, Targeted and Controlled Drug Delivery-Novel Carrier System: New Delhi, CBS Publication. 2002; 453.
17. Tansel C¸ omog˘lu, Nurs¸ in Go¨nu¨ l, Tamer Baykara, Preparation and in vitro evaluation of modified release ketoprofen Microsponges, Il Farmaco 2003; 58: 101- 106.
18. Sato T, Kanke M, Schroeder G, Deluca P: Porous biodegradable microspheres for controlled drug delivery. I: Assessment of processing conditions and solvent removal techniques. Pharm Res. 1988; 5: 21-30.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
